Noonberg Sarah B. 4
4 · MARINUS PHARMACEUTICALS, INC. · Filed May 17, 2023
Insider Transaction Report
Form 4
Noonberg Sarah B.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-16+32,400→ 32,400 totalExercise: $8.51Exp: 2033-05-16→ Common Stock (32,400 underlying) - Award
Common Stock
2023-05-16+7,200→ 7,200 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units (RSUs). The RSUs will vest in three equal annual installments, with the first installment vesting on May 16, 2024, the second installment vesting on May 16, 2025 and the third installment vesting on May 16, 2026, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
- [F2]The option vests and becomes exercisable in 36 equal monthly installments beginning on June 16, 2023, subject to the reporting person's continued service with the Issuer.